Psilera, a leading biotechnology company developing groundbreaking therapies for hard-to-treat neurological disorders, is pleased to announce the appointment of Magali Haas, M.D., Ph.D., to its esteemed Board of Directors.
Leaders of organizations that fund vision research convene in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
A new study found higher levels of neurodegeneration in rats that consumed reused deep fried cooking oils and their offspring compared to rats on a normal diet.
A team of researchers from the Case Western Reserve University School of Medicine has provided fresh insight into the dangers some common household chemicals pose to brain health.
Artist Syril Strickler was 47 when she had her first epileptic seizure, waking up in the hospital after neighbors found her unconscious in the street. For 10 years, seizures every few weeks brought her life to a virtual standstill—until Cedars-Sinai physicians performed a surgery that gave Strickler her life back.
A multidisciplinary team of neurosurgeons and neuroscientists from the Icahn School of Medicine at Mount Sinai are the first in New York to study a new brain-computer interface that’s engineered to map a large area of the brain’s surface, in real time, at resolutions hundreds of times more detailed than typical arrays used in neurosurgical procedures.
Seizures are different in newborns. Dr. Emma Carter speaks with Dr. Ronit Pressler about recent guidelines and recommendations for treating seizures in newborns and how they were established.
A new study co-led by Georgia Institute of Technology's Anna (Anya) Ivanova uncovers the relationship between language and thought in artificial intelligence models like ChatGPT, leveraging cognitive neuroscience research on the human brain. The results are a roadmap to developing new AIs — and to better understanding how we think and communicate.
Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center successfully performed the first GammaTile® implant in the state. The device was implanted in a patient with recurrent meningioma, a brain tumor, to deliver radiation immediately at the time of surgery, targeting residual cancer cells to help prevent recurrence while minimizing harm to healthy tissue.
Using novel genetic and genomic tools, researchers at the Icahn School of Medicine at Mount Sinai have shed light on the role of immune cells called macrophages in lipid-rich tissues like the brain, advancing our understanding of Alzheimer’s and other diseases.
People who have an influenza infection are more likely to need medical care for neurologic disorders within the next year than people who have a COVID-19 infection, according to a study published in the March 20, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Surgical nerve decompression, used to treat conditions such as carpal tunnel syndrome and sciatica, could play a role in relieving the pain of diabetic neuropathy patients, researchers at UT Southwestern Medical Center found.
A collaborative effort between Israeli and Italian researchers has led to the development of a new treatment strategy targeting the early-stage aggregation of A-beta before the formation of toxic oligomers.
A landmark study, led by Yen-Yu Ian Shih, PhD, at the UNC School of Medicine, shows how neurochemicals can influence blood vessels. The new findings may alter how researchers interpret results from functional magnetic resonance imaging.
Dana-Farber Cancer Institute launched the Neuro-Inclusive Oncology Care and Empowerment Program, a psychosocial oncology program that is specialized for adults with intellectual and/or developmental disabilities (IDD).
Eating fatty food in the days leading up to surgery may prompt a heightened inflammatory response in the brain that interferes for weeks with memory-related cognitive function in older adults – and, new research in animals suggests, even in young adults.
For the first time, researchers at the University of Minnesota Twin Cities showed that non-invasive brain stimulation can change a specific brain mechanism that is directly related to human behavior.
The stress-induced mechanisms that cause our brain to produce feelings of fear in the absence of threats — such as in PTSD — have been mostly a mystery. Now, neurobiologists have identified the changes in brain biochemistry and mapped the neural circuitry that cause generalized fear experiences.
A new population study led by researcher Tomas Paus , professor of psychiatry and neuroscience at the University of Montreal and researcher at CHU Sainte-Justine, highlights the respective roles of maternal and fetal genes in the growth of the baby's cerebral cortex .
“While our research does not prove that veterans who experienced these injuries will develop Alzheimer’s disease, it raises the possibility that they may be on a pathway leading to dementia,” said Dr. Ge Li, the paper's first author and an associate professor of psychiatry and behavioral sciences at UW Medicine.
Space travel and zero gravity can take a toll on the body. A new study has found that astronauts with no prior history of headaches may experience migraine and tension-type headaches during long-haul space flight, which includes more than 10 days in space. The study was published in the March 13, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Chula Medicine has designed an anti-choke mug with calculated angle, amount, and time of water flow from the mug to the patient’s lips hoping to reduce choking that may lead to lung infection, bring peace of mind to caregivers, and make it safer for patients who will have a better quality of life.
Renowned clinical geneticist Bruce Korf, MD, PhD, FACMG, has been named the recipient of the 2024 ACMG Foundation for Genetic and Genomic Medicine's David L. Rimoin Lifetime Achievement Award in Medical Genetics.
Middle-age veterans who experienced concussions due to blasts from explosive devices may have biomarkers in their spinal fluid similar to people who develop Alzheimer’s disease, according to a new study published in the March 13, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The Speech Accessibility Project, which aims to train voice recognition technologies to understand people with diverse speech patterns and disabilities, is recruiting U.S. and Puerto Rican adults with cerebral palsy.
Researchers investigating how exactly the brain processes the incoming stream of information from the heart and lungs, discovered that specific neurons in the thalamus are actively involved in processing cardiac and respiratory signals.
The Portman lab at the Del Monte Institute for Neuroscience at the University of Rochester discovered that the male roundworms use pheromones and touch signals to determine the sex, age, nutritional health, and mating history of the hermaphrodites and show preference toward worms that have not previously mated with another male and are nutritionally healthy.
Sylvester Comprehensive Cancer Center and the North American Neuroendocrine Tumor Society will present a regional educational conference on April 6 focusing on neuroendocrine tumors (NET) and the latest knowledge for optimal NET management.
The Angelman Syndrome Foundation (ASF) and the Foundation for Angelman Syndrome Therapeutics (FAST) are hosting the inaugural Angelman Syndrome (AS) Congressional Advocacy Day in Washington, D.C.
Dementia may be three times more common among people with essential tremor, a movement disorder that causes involuntary shaking, than the general population, according to research released today, March 6, 2024. The study will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.
The risk of stroke tied to sleep apnea may vary for Black people and white people, according to a study published in the March 6, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Fragile X syndrome is one of the most commonly inherited forms of autism and intellectual disability, and no treatment currently exists. But a team of University of Illinois researchers has discovered a novel receptor function that may be used in a therapeutic approach to treatment.
People who have headaches after experiencing concussions may also be more likely to have higher levels of iron in areas of the brain, which is a sign of injury to brain cells, according to a preliminary study released today, March 5, 2024, that will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.
In the mid-1990s, Dr. Edward (Ted) Reynolds, then president of ILAE, recognized that epilepsy required global solutions. His ideas blossomed into the Global Campaign Against Epilepsy and established partnerships between ILAE, the World Health Organization, and the International Bureau for Epilepsy.
New Cleveland Clinic-led research points to sildenafil (Viagra) as a potential treatment for Alzheimer’s disease. The study provides evidence from computational models, insurance claims data and observations from brain cells in Alzheimer’s patients.
Sildenafil is the main component of drugs used to treat erectile dysfunction (Viagra) and pulmonary arterial hypertension (Revatio).
Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released today, March 4, 2024. The study will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online. The study examined four monoclonal antibodies for MS: natalizumab, ocrelizumab, rituximab and ofatumumab.
The International Commission on Non-Ionizing Radiation Protection (ICNIRP) has identified a lack of consensus among public health officials about whether SWL from artificial sources disrupts circadian rhythm, and if so, whether SWL-disrupted circadian rhythm is associated with adverse health outcomes.
A special session at the American Epilepsy Society meeting in December 2023 reviewed progress on the Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders (IGAP) and discussed strategies for moving forward.
Children’s Hospital Los Angeles (CHLA) neurologist Shafali Spurling Jeste, MD, has been named the 2024 recipient of the prestigious Martha Bridge Denckla Award from the Child Neurology Society. This award—named after a physician who pioneered the field of developmental cognitive neurology—honors physician-scientists of international standing who conduct research and clinical care focused on neurodevelopmental and neurobehavioral disorders.